OOIR: Observatory of International Research

Papers

(The TQCC of Brain Tumor Pathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu	53
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation	19
Preface for Brain Tumor Pathology vol.41 issue 2	19
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma	16
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas	16
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature	15
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis	14
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	13
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies	12
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma	11
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment	10
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis	10
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors	9
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	9
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation	9
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym	9
Preface for Brain Tumor Pathology vol. 39 issue 2	8
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis	6
Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas	6
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report	6
Three-dimensional visualization of human brain tumors using the CUBIC technique	6
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles	6
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas	5
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report	5
Meningioma with trabecular architecture: a harbinger of BAP1 deficiency	5

Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma	4
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature	4
Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence	4
Reappraisal of novel molecular parameters for meningioma grading by cIMPACT-NOW update 8 proposals	4
Timing of H3K27me3 loss in secondary anaplastic meningiomas	4
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment	4
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas	4
Histopathological evaluation of dopamine receptor D2 expression in symptomatic gonadotroph pituitary neuroendocrine tumors: a case series including a rare metastatic case responsive to a dopamine agon	4
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis	4
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant	4
Activated astrocytes drive the accumulation of apolipoprotein E at the brain tumor edge	4
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation	4
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature	4